Merck & Co.'s Revenue by Segment
In fiscal year 2024, Merck & Co.'s revenue by segment (products & services) are as follows:
- Animal Health segment: $5.88 B
- Pharmaceutical segment: $57.40 B
Learn more about Merck & Co.’s Revenue by Geography
Check out competitors to Merck & Co. in a side-by-side comparison.
Explore additional financial metrics for Merck & Co..
| Animal Health | 5550000000 |
|---|---|
| Other | 1728000000 |
| Pharmaceutical | 52005000000 |
| Animal Health | 5625000000 |
|---|---|
| Other | 907000000 |
| Pharmaceutical | 53583000000 |
| Animal Health segment | 5877000000 |
|---|---|
| Pharmaceutical segment | 57400000000 |
The above chart shows Merck & Co.'s revenue percentage share by segment (products and services).
In fiscal year 2022, Merck & Co.'s revenue by segment is as follows:
- Animal Health generated $5.55 B in revenue, representing 9.36% of its total revenue.
- Other generated $1.73 B in revenue, representing 2.91% of its total revenue.
- Pharmaceutical generated $52.01 B in revenue, representing 87.72% of its total revenue.
The biggest segment for Merck & Co. is the Pharmaceutical, which represents 87.72% of its total revenue.
The smallest segment for Merck & Co. is the Other, which represents 2.91% of its total revenue.
The above chart shows Merck & Co.'s revenue percentage share by segment (products and services).
In fiscal year 2023, Merck & Co.'s revenue by segment is as follows:
- Animal Health generated $5.63 B in revenue, representing 9.36% of its total revenue.
- Other generated $907.00 M in revenue, representing 1.51% of its total revenue.
- Pharmaceutical generated $53.58 B in revenue, representing 89.13% of its total revenue.
The biggest segment for Merck & Co. is the Pharmaceutical, which represents 89.13% of its total revenue.
The smallest segment for Merck & Co. is the Other, which represents 1.51% of its total revenue.
The above chart shows Merck & Co.'s revenue percentage share by segment (products and services).
In fiscal year 2024, Merck & Co.'s revenue by segment is as follows:
- Animal Health segment generated $5.88 B in revenue, representing 9.29% of its total revenue.
- Pharmaceutical segment generated $57.40 B in revenue, representing 90.71% of its total revenue.
The biggest segment for Merck & Co. is the Pharmaceutical segment, which represents 90.71% of its total revenue.
The smallest segment for Merck & Co. is the Animal Health segment, which represents 9.29% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2022 | 2023 | 2024 |
|---|---|---|---|
| Pharmaceutical | 87.72% | 89.13% | - |
| Animal Health | 9.36% | 9.36% | - |
| Other | 2.91% | 1.51% | - |
| Animal Health segment | - | - | 9.29% |
| Pharmaceutical segment | - | - | 90.71% |
| Total Revenue | 100% | 100% | 100% |
The above chart shows the revenue trend of different segments of Merck & Co..
In fiscal year 2024, the Pharmaceutical segment generated the most revenue ($57.40 B), and the Animal Health segment generated the least revenue ($5.88 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
| Products & Services | 2022 | 2023 | 2024 |
|---|---|---|---|
| Animal Health | $5.55 B - |
$5.63 B
1.35%
|
- - |
| Animal Health segment | - - | - - | $5.88 B - |
| Other | $1.73 B - |
$907.00 M
47.51%
|
- - |
| Pharmaceutical | $52.01 B - |
$53.58 B
3.03%
|
- - |
| Pharmaceutical segment | - - | - - | $57.40 B - |
| Total Revenue | $59.28 B - |
$60.12 B
1.40%
|
$63.28 B
5.26%
|
Related
-
Agilent Technologies Revenue by Segment
-
Eli Lilly and Company Revenue by Segment
-
Stryker Corporation Revenue by Segment
-
Johnson & Johnson Revenue by Segment
-
AbbVie Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Abbott Laboratories Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
-
Pfizer Revenue by Segment
